News
Among these, the ITR1 form, more commonly called Sahaj, holds significance. Widely utilized across India, this form of ITR-1 for salaried employees is one of the most prevalent. As a straightforward ...
Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...
CRANBURY, NJ, USA I March 28, 2025 I Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of ...
BioNTech is running or planning phase 1/2 trials to show whether BNT327 pairs well with TROP2, HER2, HER3 and B7H3 antibody-drug conjugates, and its longer-term road map includes studies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results